Umemoto, S., Haruta, M., Sakisaka, M., Ikeda, T., Tsukamoto, H., Komohara, Y., . . . Senju, S. (2019). Cancer therapy with major histocompatibility complex‐deficient and interferon β‐producing myeloid cells derived from allogeneic embryonic stem cells. Cancer Sci.
Citación estilo ChicagoUmemoto, Satoshi, Miwa Haruta, Masataka Sakisaka, Tokunori Ikeda, Hirotake Tsukamoto, Yoshihiro Komohara, Motohiro Takeya, Yasuharu Nishimura, and Satoru Senju. "Cancer Therapy With Major Histocompatibility Complex‐deficient and Interferon β‐producing Myeloid Cells Derived From Allogeneic Embryonic Stem Cells." Cancer Sci 2019.
Cita MLAUmemoto, Satoshi, et al. "Cancer Therapy With Major Histocompatibility Complex‐deficient and Interferon β‐producing Myeloid Cells Derived From Allogeneic Embryonic Stem Cells." Cancer Sci 2019.